Literature DB >> 17515867

Changes in the expression of hypothalamic lipid sensing genes in rat model of intrauterine growth retardation (IUGR).

Antonella Puglianiello1, Daniela Germani, Sara Antignani, Gianpaolo Scalia Tomba, Stefano Cianfarani.   

Abstract

Intrauterine growth retardation (IUGR) has been linked to the development of type 2 diabetes in later life. The mechanisms underlying this phenomenon are unknown. Recent data suggest that some of the molecular defects underlying type 2 diabetes reside in the CNS. The enzyme carnitine palmitoyltransferase-1 (CPT1) regulates long-chain fatty acid (LCFA) entry into mitochondria, where LCFA undergo beta-oxidation. Hypothalamic inhibition of CPT1 decreases food intake and suppresses endogenous glucose production. Our aim was to investigate the effects of uterine artery ligation, a procedure that mimics uteroplacental insufficiency, on the CNS expression of CPT1 and other key enzymes of LCFA metabolism. Bilateral uterine artery ligation was performed on d 19 of gestation in the pregnant rat; sham-operated pregnant rats served as controls. Hypothalamus, cerebellum, hippocampus, and cortex were dissected and analyzed at birth by real-time PCR. Nonesterified fatty acid (NEFA) serum levels were significantly higher in IUGR pups (p<0.0001). In IUGR rats, the hypothalamic expression of CPT1 isoform C (p=0.005) and acetyl-CoA carboxylase (ACC) isoforms alpha (p<0.05) and beta (p=0.005) were significantly decreased. The data presented here support the hypothesis that an abnormal intrauterine milieu can induce changes in hypothalamic lipid sensing.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17515867     DOI: 10.1203/pdr.0b013e3180332d4e

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  8 in total

1.  Role of microRNA-122 in hepatic lipid metabolism of the weanling female rat offspring exposed to prenatal and postnatal caloric restriction.

Authors:  Yun Dai; Shubhamoy Ghosh; Bo-Chul Shin; Sherin U Devaskar
Journal:  J Nutr Biochem       Date:  2019-08-15       Impact factor: 6.048

2.  5'-AMP-activated protein kinase activity is elevated early during primary brain tumor development in the rat.

Authors:  Taichang Jang; Joy M Calaoagan; Eunice Kwon; Steven Samuelsson; Lawrence Recht; Keith R Laderoute
Journal:  Int J Cancer       Date:  2011-05-01       Impact factor: 7.396

3.  Demystifying animal models of adverse pregnancy outcomes: touching bench and bedside.

Authors:  Elizabeth A Bonney
Journal:  Am J Reprod Immunol       Date:  2013-02-28       Impact factor: 3.886

4.  Effects of Choline on Meat Quality and Intramuscular Fat in Intrauterine Growth Retardation Pigs.

Authors:  Bo Li; Wei Li; Hussain Ahmad; Lili Zhang; Chao Wang; Tian Wang
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

5.  Impact of uteroplacental insufficiency on postnatal rat male gonad.

Authors:  Valentina Pampanini; Daniela Germani; Antonella Puglianiello; Jan-Bernd Stukenborg; Ahmed Reda; Iuliia Savchuk; Kristín Rós Kjartansdóttir; Stefano Cianfarani; Olle Söder
Journal:  J Endocrinol       Date:  2016-11-24       Impact factor: 4.286

6.  Uteroplacental insufficiency down regulates insulin receptor and affects expression of key enzymes of long-chain fatty acid (LCFA) metabolism in skeletal muscle at birth.

Authors:  Daniela Germani; Antonella Puglianiello; Stefano Cianfarani
Journal:  Cardiovasc Diabetol       Date:  2008-05-18       Impact factor: 9.951

7.  The exposure to uteroplacental insufficiency is associated with activation of unfolded protein response in postnatal life.

Authors:  Annalisa Deodati; Josepmaría Argemí; Daniela Germani; Antonella Puglianiello; Anna Alisi; Cristiano De Stefanis; Roberto Ferrero; Valerio Nobili; Tomás Aragón; Stefano Cianfarani
Journal:  PLoS One       Date:  2018-06-13       Impact factor: 3.240

Review 8.  Epigenetics and In Utero Acquired Predisposition to Metabolic Disease.

Authors:  Annalisa Deodati; Elena Inzaghi; Stefano Cianfarani
Journal:  Front Genet       Date:  2020-01-29       Impact factor: 4.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.